Comgest Global Investors S.A.S. Biomarin Pharmaceutical Inc Transaction History

Comgest Global Investors S.A.S.

$6.39 Billion
Q2 2024

A detailed history of Comgest Global Investors S.A.S. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Comgest Global Investors S.A.S. holds 152,777 shares of BMRN stock, worth $10.8 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

152,777

Previous 212,464 28.09%

Holding current value

$10.8 Million

Previous $18.6 Million 32.22%

% of portfolio

0.2%

Previous 0.3%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$74.43 - $92.22 $4.44 Million - $5.5 Million	-59,687 Reduced 28.09%	152,777 $12.6 Million
Q1 2024 May 07, 2024	BUY	$83.81 - $99.0 $1.1 Million - $1.3 Million	13,143 Added 6.59%	212,464 $18.6 Million
Q4 2023 Feb 12, 2024	BUY	$76.22 - $98.51 $1.7 Million - $2.2 Million	22,313 Added 12.61%	199,321 $19.2 Million
Q3 2023 Nov 07, 2023	BUY	$85.07 - $94.48 $2.84 Million - $3.16 Million	33,401 Added 23.26%	177,008 $15.7 Million
Q2 2023 Jul 24, 2023	BUY	$86.68 - $100.3 $1.93 Million - $2.23 Million	22,273 Added 18.36%	143,607 $12.4 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $1.37 Million - $1.83 Million	-15,574 Reduced 11.38%	121,334 $11.8 Million
Q4 2022 May 15, 2023	BUY	$80.93 - $108.63 $849,198 - $1.14 Million	10,493 Added 8.3%	136,908 $14.2 Million
Q4 2022 Feb 10, 2023	BUY	$80.93 - $108.63 $849,198 - $1.14 Million	10,493 Added 8.3%	136,908 $14.2 Million
Q3 2022 May 15, 2023	BUY	$82.16 - $96.94 $542,256 - $639,804	6,600 Added 5.51%	126,415 $10.7 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $542,256 - $639,804	6,600 Added 5.51%	126,415 $10.7 Million
Q2 2022 May 15, 2023	BUY	$71.48 - $86.85 $943,750 - $1.15 Million	13,203 Added 12.38%	119,815 $9.93 Million
Q2 2022 Jul 28, 2022	BUY	$71.48 - $86.85 $943,750 - $1.15 Million	13,203 Added 12.38%	119,815 $9.93 Million
Q1 2022 May 15, 2023	SELL	$74.28 - $92.69 $1.09 Million - $1.36 Million	-14,722 Reduced 12.13%	106,612 $8.22 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $164,753 - $205,586	2,218 Added 2.12%	106,612 $8.22 Million
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $197,301 - $251,633	-2,751 Reduced 2.57%	104,394 $9.22 Million
Q3 2021 Nov 02, 2021	BUY	$74.77 - $85.47 $1.16 Million - $1.33 Million	15,529 Added 16.95%	107,145 $8.28 Million
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $105,714 - $118,706	1,400 Added 1.55%	91,616 $7.64 Million
Q1 2021 May 14, 2021	SELL	$74.73 - $90.69 $298,920 - $362,760	-4,000 Reduced 4.25%	90,216 $6.81 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $72,610 - $90,200	-1,000 Reduced 1.05%	94,216 $8.26 Million
Q3 2020 Nov 13, 2020	BUY	$71.87 - $131.03 $970,245 - $1.77 Million	13,500 Added 16.52%	95,216 $7.24 Million
Q2 2020 Jul 31, 2020	SELL	$79.55 - $124.22 $175,010 - $273,284	-2,200 Reduced 2.62%	81,716 $10.1 Million
Q1 2020 May 07, 2020	SELL	$71.37 - $96.85 $241,087 - $327,159	-3,378 Reduced 3.87%	83,916 $7.09 Million
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $1.05 Million - $1.41 Million	16,294 Added 22.95%	87,294 $7.38 Million
Q3 2019 Nov 05, 2019	BUY	$67.4 - $85.11 $889,680 - $1.12 Million	13,200 Added 22.84%	71,000 $4.79 Million
Q2 2019 Aug 08, 2019	BUY	$80.35 - $93.9 $289,260 - $338,040	3,600 Added 6.64%	57,800 $4.95 Million
Q1 2019 May 09, 2019	BUY	$84.2 - $98.62 $1.01 Million - $1.18 Million	12,000 Added 28.44%	54,200 $4.81 Million
Q4 2018 Feb 12, 2019	BUY	$80.14 - $106.07 $609,064 - $806,132	7,600 Added 21.97%	42,200 $3.59 Million
Q3 2018 Nov 06, 2018	BUY	$93.92 - $105.72 $432,032 - $486,312	4,600 Added 15.33%	34,600 $3.36 Million
Q4 2017 Feb 09, 2018	BUY	$80.76 - $95.13 $363,420 - $428,085	4,500 Added 17.65%	30,000 $2.68 Million
Q3 2017 Nov 07, 2017	BUY	$80.6 - $94.95 $120,899 - $142,425	1,500 Added 6.25%	25,500 $2.37 Million
Q2 2017 Aug 09, 2017	BUY	N/A	24,000	24,000 $2.18 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comgest Global Investors S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Comgest Global Investors S.A.S. with notifications on news.

Account

Comgest Global Investors S.A.S. Biomarin Pharmaceutical Inc Transaction History